Ink Corp. – Trademark Portfolio
Entity Type: 03
Ink Corp. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 3 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include THIS BOTTLE OF HEART MEDICINE WAS CHANNELED EXPRESSLY FOR: HEART MEDICINE 12/52/365 TAKE ONE CARD DIRECTLY TO HEART AS NEEDED. The owner is based in Royal Oak, MI.
P.O. Box 2073
Royal Oak, MI 48068
Showing of trademarks Trademarks
Trademark Classifications
Ink Corp.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Precious metals and their alloys; jewellery, precious stones; horological instruments
Common metals and their alloys; metal building materials; transportable buildings of metal
Frequently Asked Questions
How many trademarks does Ink Corp. have?
Ink Corp. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned.
What trademark classes does Ink Corp. file in?
Ink Corp. files trademarks across 5 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 16 (Paper Goods), Class 14 (Jewelry), Class 21 (Housewares), Class 6 (Metal Goods). Class 25 covers clothing, footwear, headgear.
What are Ink Corp.'s most well-known trademarks?
Ink Corp.'s registered trademark portfolio includes well-known marks such as THIS BOTTLE OF HEART MEDICINE WAS CHANNELED EXPRESSLY FOR: HEART MEDICINE 12/52/365 TAKE ONE CARD DIRECTLY TO HEART AS NEEDED. These are among 1 currently registered trademark in the portfolio.
What is Ink Corp.'s trademark registration success rate?
Ink Corp. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.